Patents by Inventor Mone Zaidi

Mone Zaidi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES BY INHIBITING FSH
    Publication number: 20240254218
    Abstract: The present disclosure provides compositions and methods for treating neurodegenerative diseases, in particular, Alzheimer's Disease, by inhibiting FSH in a subject in need thereof. A method comprising of treating Alzheimer's Disease (AD), preventing the onset of AD, or reducing cognitive or functional decline in AD, in a subject in need or at risk thereof.
    Type: Application
    Filed: July 21, 2022
    Publication date: August 1, 2024
    Inventors: Mone Zaidi, Keqiang Ye
  • Compositions and methods for reducing adiposity by inhibiting FSH/FSHR
    Patent number: 11034761
    Abstract: The present disclosure provides compositions and methods for reducing adiposity by inhibiting FSH/FHSR in a subject in need thereof.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: June 15, 2021
    Assignee: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Inventor: Mone Zaidi
  • COMPOSITIONS AND METHODS FOR REDUCING ADIPOSITY BY INHIBITING FSH/FSHR
    Publication number: 20190241651
    Abstract: The present disclosure provides compositions and methods for reducing adiposity by inhibiting FSH/FHSR in a subject in need thereof.
    Type: Application
    Filed: July 24, 2017
    Publication date: August 8, 2019
    Inventor: Mone Zaidi
  • COMBINATION CANCER THERAPY USING BISPHOSPHONATES AND ANTI-EGFR AGENTS
    Publication number: 20160038516
    Abstract: The present invention relates to combination therapies for the treatment of EGFR-related diseases, particularly EGFR-related cancers. This invention also relates to a method of enhancing the efficacy of an EGFR family member antagonist and therapeutic methods for subjects who are refractory to treatment with an EGFR family member antagonist. The invention also relates to pharmaceutical compositions useful for treatment of EGFR-related diseases.
    Type: Application
    Filed: June 25, 2013
    Publication date: February 11, 2016
    Inventors: Mone Zaidi, Goutham Narla, Jameel Iqbal
  • FSH AND FSH RECEPTOR MODULATOR COMPOSITIONS AND METHODS FOR INHIBITING OSTEOCLASTIC BONE RESORPTION AND BONE LOSS IN OSTEOPOROSIS
    Publication number: 20130287765
    Abstract: The invention discloses compositions and methods for decreasing osteoclast which are useful for the treatment of a variety of bone loss disorders.
    Type: Application
    Filed: April 12, 2013
    Publication date: October 31, 2013
    Applicants: University of Pittsburgh - of the Commonwealth System of Higher Education, Icahn School of Medicine at Mount Sinai
    Inventors: Mone Zaidi, Harry C. Blair
  • Methods for inhibiting osteoclastic bone resorption and bone loss comprising administration of an anti-FSH or anti-FSHR antibody
    Patent number: 8435948
    Abstract: The invention discloses compositions and methods for decreasing osteoclast which are useful for the treatment of a variety of bone loss disorders.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: May 7, 2013
    Assignees: Mount Sinai School of Medicine of New York University, University of Pittsburgh of the Commonwealth System of Higher Education
    Inventors: Mone Zaidi, Harry C. Blair
  • Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity
    Publication number: 20080167223
    Abstract: The present invention is direct to methods and compositions for inhibiting TNF activity. In particular it has been found that TSH may be used to inhibit the activity of TNF. Methods and compositions for exploiting this finding are described.
    Type: Application
    Filed: April 13, 2005
    Publication date: July 10, 2008
    Applicant: MOUNT SINAI SCHOOL OF MEDICINE
    Inventors: Mone Zaidi, Etsuka Abe, Terry Davies
  • Fsh and Fsh Receptor Modulator Compositions and Methods for Inhibiting Osteclastic Bone Resorption and Bone Loss in Osteoporosis
    Publication number: 20080069811
    Abstract: The invention discloses compositions and methods for decreasing osteoclast which are useful for the treatment of a variety of bone loss disorders.
    Type: Application
    Filed: September 27, 2005
    Publication date: March 20, 2008
    Applicant: MOUNT SINAI SCHOOL OF MEDICINCE OF NEW YORK UIVERSITY
    Inventors: Mone Zaidi, Harry Blair
  • Prevention of bone resorption
    Patent number: 5674887
    Abstract: The administration of a xanthine oxidase inhibitor is effective for the treatment or prevention of the excessive resorption of bone in conditions such as osteoporosis and the like.
    Type: Grant
    Filed: February 22, 1995
    Date of Patent: October 7, 1997
    Assignees: Eli Lilly and Company, London Hospital Medical College, St. George's Hospital Medical School
    Inventors: David R. Blake, Jill A. Panetta, Mone Zaidi
  • Prevention of bone resorption
    Patent number: 5436258
    Abstract: The administration of a xanthine oxidase inhibitor is effective for the treatment or prevention of the excessive resorption of bone in conditions such as osteoporosis and the like.
    Type: Grant
    Filed: September 9, 1992
    Date of Patent: July 25, 1995
    Assignees: Eli Lilly and Company, London Hospital Medical College, St. George's Hospital Medical School
    Inventors: David R. Blake, Jill A. Panetta, Mone Zaidi